SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-012979
Filing Date
2020-03-26
Accepted
2020-03-26 07:23:41
Documents
3
Period of Report
2020-03-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prvl-8k_20200326.htm 8-K 34168
2 EX-99.1 prvl-ex991_6.htm EX-99.1 185159
3 GRAPHIC g4z25e52m3fl000001.jpg GRAPHIC 11473
  Complete submission text file 0001564590-20-012979.txt   236413
Mailing Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016 917-336-9310
Prevail Therapeutics Inc. (Filer) CIK: 0001714798 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38939 | Film No.: 20744009
SIC: 2836 Biological Products, (No Diagnostic Substances)